share_log

Marker Therapeutics Shares Are Trading Higher After the Company Announced It Won a $9.5 Million Grant to Study Pancreatic Cancer Therapy.

Benzinga ·  Dec 17 21:35
Marker Therapeutics Shares Are Trading Higher After the Company Announced It Won a $9.5 Million Grant to Study Pancreatic Cancer Therapy.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment